Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Raised to $445 at JPMorgan

July 24, 2018 1:55 PM
JPMorgan raised its price target on Biogen (NASDAQ: BIIB) to $445.00 (from $400.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles